Cinven Makes Strategic Investment in Regenity Biosciences (Linden Capital Partners)

Cinven Acquires Majority Stake in BioAgilytix; Cobepa Reinvests

December 20, 2021

Healthcare Services

International private equity firm Cinven has agreed to acquire a majority stake in BioAgilytix through a recapitalization, with current investor Cobepa remaining a significant minority investor. GHO Capital has realised its investment and will exit; the transaction will provide funding to support BioAgilytix’s international expansion, capacity and capability investments, and buy-and-build strategy in large-molecule bioanalytical services. BioAgilytix is headquartered in Durham, North Carolina and employs about 870 staff across the United States, Europe and Australia.

Berkshire Partners and Leonard Green Join Linden in Strategic Investment in Vital Care

August 1, 2024

Healthcare Services

Vital Care, a Brentwood, Tennessee-based franchisor of infusion therapy pharmacies with more than 160 locations, received a strategic investment from Berkshire Partners and Leonard Green & Partners alongside existing investor Linden Capital Partners. The capital will support franchisee reinvestment, operational enhancements, and continued expansion to increase access to infusion therapy across the U.S.; financial terms were not disclosed.

Cinven Makes Strategic Investment in Alter Domus

March 4, 2024

Financial Services

International private equity firm Cinven has agreed to make a significant majority/strategic investment in Alter Domus, valuing the company at an enterprise value of €4.9 billion. Permira and the company's founders will sell approximately half of their shares to Cinven but will remain significant shareholders as Cinven supports further international growth, tech investment and buy-and-build expansion; the transaction is subject to customary regulatory approvals.

Linden Capital Partners Majority Recapitalizes BioIVT from Arsenal Capital Partners

October 5, 2021

Healthcare Services

Linden Capital Partners has completed a majority recapitalization of BioIVT, a Westbury, New York-based provider of mission-critical biological specimens and value-added services, alongside continuing investor Arsenal Capital Partners and BioIVT management. Financial terms were not disclosed; Linden will support BioIVT’s plans to accelerate organic growth and pursue acquisitions, with debt financing provided by funds managed by Ares Management’s Credit Group and Golub Capital.

Cinven Invests in Nitel

November 18, 2021

Telecommunications

Cinven has agreed to make a significant majority investment in Nitel, a Chicago-based provider of managed internet connectivity, SD-WAN and managed cybersecurity services for multi-site SMEs. Financial terms were not disclosed; the deal is an acquisition from the founders and Cinven intends to support Nitel’s organic growth and buy-and-build strategy to expand into adjacent services.

Linden Capital Partners Acquires Alcresta Therapeutics

March 12, 2024

Medical Devices

Chicago-based private equity firm Linden Capital Partners has completed its acquisition of Alcresta Therapeutics from a group led by Athyrium Capital, with Bessemer Venture Partners, Frazier Healthcare Partners and HealthQuest Capital also selling (HealthQuest reinvested as a minority shareholder). Linden will work with Alcresta's management and a newly assembled board to support the commercial launch of the next-generation RELiZORB device and accelerate R&D and growth.